FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

21609811000001108: Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71610301000001117 Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80001601000001118 Forxiga 10mg tablets (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Dapagliflozin 10mg tablets true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Dapagliflozin 10mg tablets false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Dapagliflozin 10mg tablets false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Forxiga true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Dapagliflozin false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Forxiga 10mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start